1-4 of 4
Norbert Weiss
Close
Sort by
Journal Articles

Drug Persistence with Rivaroxaban Therapy in Atrial Fibrillation Patients Results from the Dresden NOAC registry

Jan Beyer-Westendorf, MD, Kati Förster, Franziska Ebertz, Vera Gelbricht, Franziska Michalski, Luise Tittl, Norbert Weiss, Prof.
Journal: Blood
Blood (2014) 124 (21): 4264.
https://doi.org/10.1182/blood.V124.21.4264.4264
Published: 2014
Journal Articles

Characteristics of Atrial Fibrillation Patients Not Switched from Vka to Noac and Persistence on Vka – a Subgroup Analysis of the Prospective Dresden Noac Registry (NCT01588119)

Jan Beyer-Westendorf, MD, Franziska Michalski, Sebastian Werth, MD, Luise Tittl, Christina Köhler, MD, Norbert Weiss, Prof.
Journal: Blood
Blood (2014) 124 (21): 1538.
https://doi.org/10.1182/blood.V124.21.1538.1538
Published: 2014
Journal Articles

Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry

Clinical Trials & Observations
Jan Beyer-Westendorf, Kati Förster, Sven Pannach, Franziska Ebertz, Vera Gelbricht, Christoph Thieme, Franziska Michalski, Christina Köhler, Sebastian Werth, Kurtulus Sahin, Luise Tittl, Ulrike Hänsel, Norbert Weiss
Journal: Blood
Blood (2014) 124 (6): 955–962.
https://doi.org/10.1182/blood-2014-03-563577
Published: 2014
Includes: Supplemental data
Journal Articles

Efficacy and Safety of VTE Prophylaxis with Oral Rivaroxaban Compared to Fondaparinux or Low-Molecular Weight Heparin In a Large Cohort of Consecutive Patients Undergoing Major Orthopaedic Surgery

Jan Beyer-Westendorf, MD, Lars Donath, Jörg Lützner, MD, Sebastian Werth, MD, Oliver Radke, MD, Klaus-Peter Guenther, Prof., Norbert Weiss, Prof.
Journal: Blood
Blood (2011) 118 (21): 210.
https://doi.org/10.1182/blood.V118.21.210.210
Published: 2011